Showing results (21-30 of 109) with videos related to
Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Synthesis of 1H-pyridin-2-one derivatives as potent and selective farnesyltransferase inhibitorsLe Wang, Nan-Horng Lin, Qun Li, et al.Journal of Medicinal Chemistry|July 11, 2009
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationshipsChen Zhao, Minghua Sun, Youssef L Bennani, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|August 29, 2025
Rat and dog quad-culture liver chip models: Characterization and use to interrogate a potential flavin-containing monooxygenase-mediated, species-specific toxicity of a histamine receptor antagonistDavid Kukla, Tatiana A Sharapova, Rita Ciurlionis, et al.Biochemical Pharmacology|September 15, 2007
A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal modelsJianguo Ji, William H Bunnelle, David J Anderson, et al.Journal of Cardiovascular Pharmacology|September 23, 2009
Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogsJames S Polakowski, Andrew J King, Thomas J Campbell, et al.Clinical and Experimental Pharmacology & Physiology|February 6, 2010
Tumour-selective antivascular effects of the novel anti-mitotic compound A-318315: An in vivo rat regional haemodynamic studyJason A Segreti, Kristin A Brooks, Kennan C Marsh, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 2Anil Vasudevan, Dariusz Wodka, Mary K Verzal, et al.Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 3Andrew J Souers, Dariusz Wodka, Ju Gao, et al.Clinical Pharmacokinetics|March 27, 2025
Pharmacokinetics and Safety of Navitoclax in Hepatic ImpairmentMaulik Patel, Jalaja Potluri, Thomas Marbury, et al.Clinical Science (London, England : 1979)|August 24, 2002
Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studiesJerry L Wessale, Andrew L Adler, Eugene I Novosad, et al.Pageof 11